The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019

[F1Amendment of regulation 95 (offences in connection with application)U.K.

This section has no associated Explanatory Memorandum

92.  In regulation 95—

(a)in sub-paragraph (c), before “fails” insert “, in relation to an EU marketing authorisation for a product for sale or supply in Northern Ireland,”;

(b)in sub-paragraph (d), before “provides” insert “, in relation to an EU marketing authorisation for a product for sale or supply in Northern Ireland,”.]

Textual Amendments

F1Reg. 92 substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 69

Commencement Information

I1Reg. 92 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1